The KIDS (Korea Institute of Drug Safety and Risk Management) was established according to the regulation of Article 68-3 of Pharmaceutical Affairs Act to collect, manage, analyze, evaluate and provide various information related to drug safety such as adverse drug events and drug labeling information.